TEVA PHARMACEUTICAL INDUSTRIES LTD Quarterly Common Stock, Shares, Issued from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Teva Pharmaceutical Industries Ltd quarterly Common Stock, Shares, Issued history and growth rate from Q1 2010 to Q3 2024.
  • Teva Pharmaceutical Industries Ltd Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 1.24B shares, a 1.06% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 1.24B +13M +1.06% Sep 30, 2024 10-Q 2024-11-06
Q2 2024 1.24B +12M +0.98% Jun 30, 2024 10-Q 2024-07-31
Q1 2024 1.24B +12M +0.98% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 1.23B +10M +0.82% Dec 31, 2023 10-Q 2024-11-06
Q3 2023 1.23B +11M +0.91% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 1.23B +1.23B Jun 30, 2023 10-Q 2023-08-02
Q1 2023 1.23B +10M +0.82% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 1.22B +8M +0.66% Dec 31, 2022 10-K 2024-02-12
Q3 2022 1.22B +7M +0.58% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 1.22K* -1.21B Jun 30, 2022 10-Q 2022-07-27
Q1 2022 1.22B +8M +0.66% Mar 31, 2022 10-Q 2022-05-03
Q4 2021 1.21B +7M +0.58% Dec 31, 2021 10-K 2023-02-10
Q3 2021 1.21B +7M +0.58% Sep 30, 2021 10-Q 2021-10-27
Q2 2021 1.21B +7M +0.58% Jun 30, 2021 10-Q 2021-07-28
Q1 2021 1.21B +7M +0.58% Mar 31, 2021 10-Q 2021-04-28
Q4 2020 1.2B +4M +0.33% Dec 31, 2020 10-K 2022-02-09
Q3 2020 1.2B +4M +0.33% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 1.2B +4M +0.33% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 1.2B +3M +0.25% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 1.2B +2M +0.17% Dec 31, 2019 10-K 2021-02-10
Q3 2019 1.2B +73M +6.49% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 1.2B +74M +6.58% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 1.2B +74M +6.58% Mar 31, 2019 10-Q 2019-05-02
Q4 2018 1.2B +72M +6.41% Dec 31, 2018 10-K 2020-02-21
Q3 2018 1.13B Sep 30, 2018 10-Q 2018-11-01
Q2 2018 1.12B Jun 30, 2018 10-Q 2018-08-02
Q1 2018 1.12B Mar 31, 2018 10-Q 2018-05-03
Q4 2017 1.12B +1M +0.09% Dec 31, 2017 10-K 2019-02-19
Q4 2016 1.12B +107M +10.5% Dec 31, 2016 20-F 2017-02-15
Q3 2016 1.12B +162M +16.9% Sep 30, 2016 6-K 2016-11-15
Q2 2016 1.02B +62M +6.46% Jun 30, 2016 6-K 2016-08-04
Q1 2016 1.02B +63M +6.57% Mar 31, 2016 6-K 2016-05-09
Q4 2015 1.02B +59M +6.17% Dec 31, 2015 20-F 2017-02-15
Q3 2015 961M +9M +0.95% Sep 30, 2015 6-K 2015-10-29
Q2 2015 960M +9M +0.95% Jun 30, 2015 6-K 2015-07-30
Q1 2015 959M +10M +1.05% Mar 31, 2015 6-K 2015-04-30
Q4 2014 957M +10M +1.06% Dec 31, 2014 20-F 2016-02-11
Q3 2014 952M +8M +0.85% Sep 30, 2014 6-K 2014-10-30
Q2 2014 951M +7M +0.74% Jun 30, 2014 6-K 2014-07-31
Q1 2014 949M +5M +0.53% Mar 31, 2014 6-K 2014-05-02
Q4 2013 947M +3M +0.32% Dec 31, 2013 20-F 2015-02-09
Q3 2013 944M +1M +0.11% Sep 30, 2013 6-K 2013-10-31
Q2 2013 944M +1M +0.11% Jun 30, 2013 6-K 2013-08-01
Q1 2013 944M +2M +0.21% Mar 31, 2013 6-K 2013-05-02
Q4 2012 944M +2M +0.21% Dec 31, 2012 20-F 2014-02-10
Q3 2012 943M +2M +0.21% Sep 30, 2012 6-K 2012-11-01
Q2 2012 943M +3M +0.32% Jun 30, 2012 6-K 2012-08-02
Q1 2012 942M +2M +0.21% Mar 31, 2012 6-K 2012-05-09
Q4 2011 942M +5M +0.53% Dec 31, 2011 20-F 2013-02-12
Q3 2011 941M +5M +0.53% Sep 30, 2011 6-K 2011-11-02
Q2 2011 940M +5M +0.54% Jun 30, 2011 6-K 2011-07-28
Q1 2011 940M +9M +0.97% Mar 31, 2011 6-K 2011-05-11
Q4 2010 937M Dec 31, 2010 20-F 2012-02-17
Q3 2010 936M Sep 30, 2010 6-K 2010-11-02
Q2 2010 935M Jun 30, 2010 6-K 2010-07-27
Q1 2010 931M Mar 31, 2010 6-K 2010-05-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.